Artivion IncEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 27.55 USD | 48,25 USD | 19,16 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 42 USD | 4 | 2 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 48.543.350 | 6,19 | 3,03 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Artivion Inc
Mitarbeiter 1.800
Handelsplatz NYSE
Ticker Symbol AORT
IPO Datum 1993-02-12
Adresse 1655 Roberts Boulevard NW, Kennesaw, GA, United States, 30144
Webseite https://artivion.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. James Patrick Mackin | Chairman, President & CEO |
| 2 | Mr. Lance A. Berry CPA | EVP, COO, CFO & Treasurer |
| 3 | Ms. Jean F. Holloway Esq. | Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary |
| 4 | Mr. John E. Davis | Senior VP & Chief Commercial Officer |
| 5 | Ms. Amy D. Horton CPA | VP & Chief Accounting Officer |
| 6 | Mr. Matthew A. Getz | VP of Human Resources & Chief Human Resources Officer |
| 7 | Mr. Jason D. Asper | Senior VP and Chief Strategy & Digital Officer |
| 8 | Mr. Andrew M. Green | Senior Vice President of Regulatory & Quality |
| 9 | Dr. Simona Zannetti M.D. | Senior Vice President of Clinical Research & Chief Medical Officer |
| 10 | Dr. Robert C. Thomson Ph.D. | Vice President of Research & Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Osterweis Capital Management Inc | 0,00% | 0,00 Mio. USD |